Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
Citation Manager Formats
Make Comment
See Comments

In the Special Article “Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society” by Oskoui et al.,1 the following disclaimer/publication statement should have been included: “These guidelines were jointly developed by the American Academy of Neurology Institute and American Headache Society. This article was peer reviewed and first published by Neurology, and subsequently published in Headache.” The publisher regrets the error.
- © 2019 American Academy of Neurology
Reference
- 1.↵
- Oskoui M,
- Pringsheim T,
- Billinghurst L, et al
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.